United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$325Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Goldman Sachs
Temasek Holdings
Cormorant Asset Management
Viking Global
Terra Magnum Capital PartnersReported by FinSMEsSEC filing: $75M sold, first sale Jun 2019
Reported by FinSMEsSEC filing: $282M sold, first sale Feb 2018
From the SEC filings it signed: 1 on the team.
On the board, as filediAndreas WickiEdward HuPascal SoriotTyrell RiversWenkai XiangXiaomeng TongYanling Cao
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Viela Bio's investors include Temasek Holdings, HBM Healthcare Investments, Goldman Sachs, Hill House Capital and Cormorant Asset Management, and 6 more on record. HBM Healthcare Investments led its latest round.
Viela Bio has raised $325M across 2 rounds since 2018.
Viela Bio's most recent round was a Series B of $75M in Jun 2019, led by HBM Healthcare Investments.
Viela Bio's largest round on record is $250M (Series A), in Feb 2018.
Viela Bio's first round on record, in Feb 2018, was backed by Temasek Holdings, Hill House Capital and Boyu Capital and 2 others.
Viela Bio's latest named round is a Series B, in Jun 2019.
Viela Bio is based in the United States.
HBM Healthcare Investments led the Series B in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
